Geneos Wealth Management Inc. trimmed its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 1.2% during the 4th quarter, HoldingsChannel reports. The firm owned 17,884 shares of the company’s stock after selling 211 shares during the period. Geneos Wealth Management Inc.’s holdings in Cardinal Health were worth $2,115,000 as of its most recent filing with the SEC.
A number of other large investors have also made changes to their positions in CAH. Harel Insurance Investments & Financial Services Ltd. boosted its holdings in shares of Cardinal Health by 16.7% in the fourth quarter. Harel Insurance Investments & Financial Services Ltd. now owns 43,819 shares of the company’s stock worth $5,182,000 after buying an additional 6,260 shares during the last quarter. CX Institutional bought a new position in Cardinal Health in the fourth quarter worth approximately $267,000. MFA Wealth Services purchased a new position in shares of Cardinal Health during the 4th quarter worth $292,000. Verde Capital Management purchased a new stake in shares of Cardinal Health in the 4th quarter worth $220,000. Finally, Raleigh Capital Management Inc. raised its holdings in Cardinal Health by 29.6% in the 4th quarter. Raleigh Capital Management Inc. now owns 464 shares of the company’s stock worth $55,000 after purchasing an additional 106 shares during the period. 87.17% of the stock is currently owned by institutional investors.
Cardinal Health Trading Down 0.3 %
Shares of CAH stock opened at $128.89 on Monday. The stock has a market capitalization of $31.19 billion, a price-to-earnings ratio of 25.08, a price-to-earnings-growth ratio of 1.57 and a beta of 0.63. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $129.68. The stock’s 50-day moving average price is $121.36 and its 200-day moving average price is $113.16.
Cardinal Health Cuts Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were given a dividend of $0.5056 per share. The ex-dividend date was Thursday, January 2nd. This represents a $2.02 annualized dividend and a yield of 1.57%. Cardinal Health’s dividend payout ratio (DPR) is currently 39.30%.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft boosted their price target on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a report on Monday, November 4th. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $132.00 to $145.00 in a research note on Monday, January 6th. Morgan Stanley raised their target price on shares of Cardinal Health from $127.00 to $136.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 17th. Citigroup upped their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research report on Friday, January 10th. Finally, Barclays raised their price objective on shares of Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a research report on Monday, November 4th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $134.64.
View Our Latest Analysis on CAH
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
- Five stocks we like better than Cardinal Health
- Pros And Cons Of Monthly Dividend Stocks
- MP Materials: Rare Earth Elements Powering the EV Boom
- 3 Stocks to Consider Buying in October
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- How to Invest in the Best Canadian Stocks
- Bloom Energy: Powering the Future With Decentralized Energy
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.